343330-71-2

Upstream product

• 580-17-6 3-aminoquinoline 
• 122-51-0 orthoformic acid triethyl ester 
• 13061-96-6 dihydroxy-methyl-borane 
• 74-88-4 methyl iodide 
• 191162-39-7 quinolin-3-ylboronic acid 
• 75-52-5 nitromethane 
• 67-56-1 methanol 
• 149-73-5 trimethyl orthoformate 

Relevant academic research and scientific papers

The effect of N-methylation on photophysical properties of 3-aminoquinoline

It has been reported previously that the photophysics of 3-aminoquinoline (3AQ) is governed by a flip-flop motion of its amino group in apolar solvents and intersystem crossing in polar solvents. The nonradiative rates are governed by more than one solvent parameters, like polarity and hydrogen bonding ability of the solvent. So, 3AQ is not a well-behaved probe of any individual solvent parameter. In the present work, 3AQ has been modified synthetically; replacing an amino hydrogen atom with a methyl group and photophysical properties were studied in 22 different apolar, polar-aprotic and polar-protic solvents. It is found that Stokes' shifts and fluorescence quantum yields exceptionally low in apolar solvents as compared to those in other solvents. Such substitution causes a decrease in the extent of the effect of the hydrogen bonding ability of the solvent and that nonradiative rate become a more regular function of polarity. However, the flip-flop appears to continue to be the major nonradiative pathway, as the nonradiative rates decrease with increase in micropolarity.

P(III)/P(V)-Catalyzed Methylamination of Arylboronic Acids and Esters: Reductive C-N Coupling with Nitromethane as a Methylamine Surrogate

The direct reductive N-arylation of nitromethane by organophosphorus-catalyzed reductive C-N coupling with arylboronic acid derivatives is reported. This method operates by the action of a small ring organophosphorus-based catalyst (1,2,2,3,4,4-hexamethylphosphetane P-oxide) together with a mild terminal reductant hydrosilane to drive the selective installation of the methylamino group to (hetero)aromatic boronic acids and esters. This method also provides for a unified synthetic approach to isotopically labeled N-methylanilines from various stable isotopologues of nitromethane (i.e., CD3NO2, CH315NO2, and 13CH3NO2), revealing this easy-to-handle compound as a versatile precursor for the direct installation of the methylamino group.

Well-Defined Phosphine-Free Iron-Catalyzed N-Ethylation and N-Methylation of Amines with Ethanol and Methanol

An iron(0) complex bearing a cyclopentadienone ligand catalyzed N-methylation and N-ethylation of aryl and aliphatic amines with methanol or ethanol in mild and basic conditions through a hydrogen autotransfer borrowing process is reported. A broad range of aromatic and aliphatic amines underwent mono- or dimethylation in high yields. DFT calculations suggest molecular hydrogen acts not only as a reducing agent but also as an additive to displace thermodynamic equilibria.

Structure-Activity Relationship for Small Molecule Inhibitors of Nicotinamide N-Methyltransferase

Nicotinamide N-methyltransferase (NNMT) is a fundamental cytosolic biotransforming enzyme that catalyzes the N-methylation of endogenous and exogenous xenobiotics. We have identified small molecule inhibitors of NNMT with >1000-fold range of activity and developed comprehensive structure-Activity relationships (SARs) for NNMT inhibitors. Screening of N-methylated quinolinium, isoquinolinium, pyrididium, and benzimidazolium/benzothiazolium analogues resulted in the identification of quinoliniums as a promising scaffold with very low micromolar (IC50 à 1 μM) NNMT inhibition. Computer-based docking of inhibitors to the NNMT substrate (nicotinamide)-binding site produced a robust correlation between ligand-enzyme interaction docking scores and experimentally calculated IC50 values. Predicted binding orientation of the quinolinium analogues revealed selective binding to the NNMT substrate-binding site residues and essential chemical features driving protein-ligand intermolecular interactions and NNMT inhibition. The development of this new series of small molecule NNMT inhibitors direct the future design of lead drug-like inhibitors to treat several metabolic and chronic disease conditions characterized by abnormal NNMT activity.

Selective monomethylation of anilines by Cu(OAc)2-promoted cross-coupling with MeB(OH)2

N-Methylanilines are readily synthesized in high yields through the copper(ll)-promoted coupling of anilines and methylboronic acid. This method represents a new approach for the selective monomethylation of anilines, and it is the first reported example

QUINOLINE-DERIVED AMIDE MODULATORS OF VANILLOID VR1 RECEPTOR

This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to quinoline-derived amides that are potent antagonists or agonists of VR1 which are useful for the treatment and prevention of inflammatory and other pain conditions in mammals.